
3d3 min read
Medical Article
Introduction: Bladder cancer is the ninth most common malignancy worldwide, with nearly 75% of cases presenting as non-muscle-invasive bladder cancer (NMIBC) (1). Among these, high-risk NMIBC including high-grade Ta (Non-invasive papillary carcinoma), T1 (tumor invades the lamina propria), and CIS (carcinoma in situ) carry a significant risk of rec

CREST Phase 3 Trial: Sasanlimab Plus BCG in BCG-naive High-risk Non-Muscle-Invasive Bladder Cancer
Similar Content

Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2465 Reached4 Comments6 Likes

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments

Vildagliptin in Reducing Risk of Post-partum Diabetes
2385 Reached7 Comments4 Likes

How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes